Introduction
Nowadays, T cell receptor gamma (TCRG) gene rearrangements are frequently utilized as clonality markers and as PCR targets for the detection of minimal residual disease (MRD) in lymphoproliferative disorders. The latter application is particularly relevant in acute lymphoblastic leukemia (ALL), since TCRG gene rearrangements occur in the vast majority of T-ALL and in approximately 60% of precursor-B-ALL patients. 1, 2 Several retrospective studies and recently also two large prospective MRD studies successfully employed TCRG gene rearrangements as leukemia-specific PCR targets. [3] [4] [5] [6] [7] The frequencies and patterns of TCRG gene rearrangements in T-ALL were addressed by several Southern blot (SB)-based studies. [8] [9] [10] [11] [12] Biallelic rearrangements were found in the vast majority of patients and preferential usage of the J␥2 gene complex was strongly suggested. 1, 12 There was some indication on differential V␥ gene utilization in CD3
+ vs CD3 − negative T-ALL subsets, but such observations were generally based on limited numbers of patients. 11 Currently, PCR-based methodologies are more frequently applied for the detection of clonal TCRG gene rearrangements. However, the vast majority of PCR-based studies on TCRG genes in T-ALL, were based either on small or restricted patient groups or on limited primer combinations. [13] [14] [15] [16] [17] Therefore, we performed extensive heteroduplex PCR analysis of TCRG gene rearrangements in a large group of 126 T-ALL patients. The majority of patient samples were also studied in parallel by SB as a reference technique. Based on the combined SB and heteroduplex PCR results, we were able to determine the presence of oligoclonality and illegitimate recombinations as well as to compare TCRG gene rearrangement patterns between childhood and adult T-ALL patients, and to compare between different immunophenotypic subgroups of T-ALL.
Materials and methods

Patient description
Peripheral blood (PB) or bone marrow (BM) samples from 126 T-ALL patients (90 children and 36 adults) were obtained at initial diagnosis. 16, 18 Mononuclear cells (MNC) were isolated from PB or BM samples by Ficoll-Paque centrifugation (density 1.077 g/cm 3 ; Pharmacia, Uppsala, Sweden) and subjected to detailed immunophenotyping according to standard protocols. 19, 20 To analyze sufficient numbers of CD3 + T-ALL (especially TCR␥␦ + T-ALL) T-ALL cell samples were selected based on their CD3/TCR immunophenotype resulting in 64 CD3 − T-ALL (51% of the total series), 33 TCR␣␤ + T-ALL (26%), and 29 TCR␥␦ + T-ALL (23%). In an entirely random series of T-ALL this immunophenotype distribution would approximate 70%, 20% and 10%, respectively. 21 
Southern blot analysis
SB analysis was performed in 117 of the 126 patients. DNA was isolated from frozen MNC, digested, and blotted to nylon membranes as described previously. 22 The TCRG gene configuration was studied using the TCRGJ13 probe (DAKO Corporation, Carpinteria, CA, USA) in EcoRI digests together with either the TCRGJ21 probe (DAKO) in PstI digests or a combination of the J␥2.1 probe in EcoRI digests and the J␥1.2 probe in BglII digests. 12, 23 The information on the SB configuration of TCRG genes was reported before for 70 T-ALL patients. 12, 16, 17 
PCR amplification and heteroduplex analysis of PCR products
All patient samples were subjected to detailed PCR analysis, which was essentially performed as described previously. 16, 24 In each 50 l PCR reaction 50 ng DNA sample, 6.3 pmol of the 5′ and 3′ oligonucleotide primers, and 0.5 U AmpliTaq Gold polymerase (PE Biosystems, Foster City, CA, USA) were used. The sequences of the oligonucleotides used for amplification of TCRG gene rearrangements (four V␥ family-specific primers, six V␥I member-specific primers, and three J␥ primers) were published before. 24 PCR conditions were: initial denaturation for 10 min at 94°C, followed by 35 cycles of 45 s at 94°C, 90 s at 60°C, and 2 min at 72°C using a Perkin-Elmer 480 thermal cycler (PE Biosystems). After the last cycle an additional extension step of 10 min at 72°C was performed. Appropriate positive and negative controls were included in all experiments. 24 The results of PCR analysis of TCRG gene rearrangements in 22 adult T-ALL patients were reported before. 16 All other 104 T-ALL patients were newly analyzed for this study.
For heteroduplex analysis, the PCR products were denatured at 94°C for 5 min after the final cycle of amplification and subsequently cooled to 4°C for 60 min to induce duplex formation. 25 Afterwards the duplexes were immediately loaded on 6% non-denaturing polyacrylamide gels in 0.5 × Tris-borate-EDTA (TBE) buffer, run at room temperature, and visualized by ethidium bromide staining. 25 A 100-bp DNA ladder (Promega Corporation, Madison, WI, USA) was used as size marker.
Sequence analysis of TCRG gene rearrangements
When assignment for V␥ and/or J␥ gene segments was not possible in particular rearrangements based on combined SB and PCR information, clonal PCR products as found by heteroduplex analysis were sequenced directly. Sequencing was performed using the dye-terminator cycle sequencing kit with AmpliTaq DNA polymerase FS on an ABI 377 sequencer (PE Biosystems) as previously described. 26 V␥ and J␥ gene segments were identified by comparison to germline TCRG sequences as described before. 27 
Statistical analysis
Statistical analysis using the 2 test on a 2 × 2 table was performed to compare the frequencies of particular TCRG gene rearrangements between childhood and adult T-ALL patients, and between different immunophenotypic subgroups of T-ALL. A value of P Ͻ 0.05 was regarded to be statistically significant.
Results
Spectrum of TCRG gene rearrangements in T-ALL
Based on the combined SB and heteroduplex PCR analyses, we were able to determine the TCRG gene configuration in a Leukemia large group of 126 T-ALL patients in detail (Table 1 ). In the vast majority of cases (115 patients; 91%) both TCRG alleles were rearranged ( Figure 1 ). In one of these patients three rearranged bands of comparable density were found by SB, strongly suggesting trisomy 7. In five patients (4%) both TCRG alleles were in germline configuration, suggesting an immunogenotypically very immature T-ALL. Monoallelic rearrangements were found in six patients (5%), with the second allele in germline configuration in three cases and deleted in the other three cases. In only five patients (4%) did combined SB and PCR data indicate the presence of minor subclones as identified by additional TCRG gene rearrangements, demonstrating that oligoclonality in TCRG genes is rare in T-ALL.
Analysis of V␥ gene segment usage revealed the utilization of the most upstream V␥2 segment ( Figure 2 ) in 62 (26%) rearrangements. Interestingly, in four patients the V␥2-J␥2.3 rearrangement contained an interstitial deletion of approximately 170 bp ( Figure 1 ). Two other members of the V␥I family were also frequently used, ie the V␥4 and the V␥8 gene segments on 34 (14%) and 42 (18%) alleles, respectively. Altogether, the V␥I family segments were involved in 175 (73%) rearrangements. The single members of the other three families were identified in 57 joinings, with the V␥9 (V␥II) gene used most frequently (26 rearrangements; 11%). In five rearrangements detected by SB the V␥ segment could not be identified, which suggests that in these cases an illegitimate recombination might have occurred, eg a chromosomal translocation involving the TCRG locus.
Analysis of J␥ gene utilization showed a preferential usage of the most downstream J␥2.3 segment (Figure 2 ), which was identified in 179 (76%) rearrangements. The other gene segment of the second J␥ cluster, ie the J␥2.1 gene, was identified in 22 rearrangements (9%). Recombination to the first J␥ cluster was found on 36 alleles (15%) with J␥1.1 and J␥1.3 seg- T167  T149  T015  T198  T156 -8.0 - T015  T198  T140  T178  T192  T183  T103  T149 G
Figure 1
Southern blot analysis of the TCRG gene configuration in 10 of the studied T-ALL patients. Hybridization of PstI digests with the TCRGJ21 probe and EcoRI digests with the TCRGJ13 probe revealed biallelic rearrangements in all 10 cases. In two patients (T178 and T192) SB indicated the presence of a truncated V␥2 segment, which was subsequently confirmed by heteroduplex PCR analysis. In patient T015 the rearrangement of the V␥7 gene to J␥2.3 segment is virtually indistinguishable from the germline J␥2.3 band derived from the other allele. ments used most frequently on 14 (6%) and 20 (8%) alleles, respectively. Rearrangements involving the J␥1.2 gene segment were identified in only two patients; both joinings concerned the V␥9 gene coupling. One of these V␥9-J␥1.2 rearrangements contained a canonical junctional region based on the absence of N-nucleotide insertion and with a deletion of three overlapping homologous nucleotides, which is preferentially expressed by normal peripheral blood TCR␥␦ + cells. 28 In contrast, the junctional region of the other V␥9-J␥1.2 rearrangement contained 11 inserted N-nucleotides.
TCRG gene rearrangements in adult vs pediatric patients
TCRG gene rearrangement patterns were compared between adult and pediatric patients (Table 1 ). This analysis revealed that the TCRG configuration was largely comparable between these two patient groups. Although in adult patients the TCRG alleles were more frequently in germline configuration (11% vs 4% in pediatric ALL), frequently involved the J␥1 segments (22% vs 13%), and used the V␥9 gene segment less frequently (6% vs 13%), these findings did not reach statistical significance.
TCRG gene rearrangements in different immunophenotypic subsets
Analysis of TCRG gene rearrangements in the three major immunophenotypic T-ALL groups revealed largely comparable configuration patterns (Table 2) . Nevertheless, several discrete differences were observed. Firstly, within the CD3 − group there was a small subset with TCRG genes in germline configuration (five patients), whereas all CD3 + leukemias displayed at least a monoallelic rearrangement. Secondly, TCR␥␦ + T-ALL displayed several distinct characteristics. This immunophenotypic subset was characterized by preferential usage of the V␥9 (V␥II) gene, which was found in 22% of rearrangements, as compared to 8% in the non-TCR␥␦ + T-ALL group (P Ͻ 0.01). This was still significant when TCR␥␦ + T-ALL was independently compared to TCR␣␤ + and CD3 − T-ALL (P Ͻ 0.05). Altogether, the three most downstream V␥ members were slightly overrepresented in TCR␥␦ + T-ALL (36% vs 20% in non-TCR␥␦ + T-ALL; P Ͻ 0.05). Moreover, the J␥ segments of the upstream J␥1 cluster, particularly the J␥1.3 gene, were more frequently used in TCR␥␦ + T-ALL (28%), when compared to non-TCR␥␦ T-ALL (11%; P Ͻ 0.01).
Discussion
We studied the TCRG gene configuration in a large series of 126 T-ALL patients. Based on the combined SB and PCR 
In a single adult CD3 − T-ALL patient three rearranged bands of comparable density were found on SB analysis, suggesting trisomy 7. b Gene segments significantly overrepresented in TCRG gene rearrangements of TCR␥␦ + T-ALL as compared to non-TCR␥␦ T-ALL Leukemia results, we were able to establish several characteristics of TCRG genes in T-ALL, which were also suggested in previous molecular studies. [8] [9] [10] Firstly, we found TCRG gene rearrangements in 96% of patients, involving both alleles in most cases. Nevertheless, we could identify a small subset of five CD3 − T-ALL with both TCRG genes in germline configuration. They most probably are immunogenotypically very immature leukemias, because three of these five patients also had germline T cell receptor delta (TCRD) genes. Secondly, we confirmed the earlier observation of preferential usage of J␥ segments from the downstream J␥2 cluster (85% of rearrangements), particularly of the J␥2.3 gene segment (76%). 12, 29 In addition, we showed preferential usage of the V␥2 segment, which was present in more than a quarter of all joinings. Together, rearrangements concerning this most upstream V␥2 gene segment and/or the most downstream J␥2.3 gene were found on 83% of rearranged alleles and can be perceived as 'end-stage' recombination events. Moreover, four of the V␥2-J␥2.3 joinings contained an interstitial deletion of approximately 170 bp in the V␥2 gene segment, most probably resulting from rearrangement to a recombination signal sequence within the V␥2 gene. 30 We could also demonstrate that TCRG oligoclonality is a rare phenomenon in T-ALL, occurring in less than 5% of patients. The TCRG gene rearrangement patterns in T-ALL are strikingly different from the cross-lineage TCRG gene rearrangements in precursor-B-ALL. The latter involve J␥1 segments in approximately 70% of alleles and show oligoclonality in 38% of precursor-B-ALL patients with TCRG gene rearrangements. 2 This on one hand might reflect differences in accessibility of the TCRG locus to V(D)J recombinase activity between T-ALL and precursor-B-ALL. On the other hand, lineage promiscuity of TCRG rearrangements in precursor-B-ALL and lack of lineage-specific enhancement might favor the usage of more proximal gene segments. The rare occurrence of TCRG oligoclonality in T-ALL might indicate that the malig-nant transformation occurred in thymocytes with completed TCRG gene rearrangement processes. In contrast, the more frequent TCRG gene oligoclonality in precursor-B-ALL is one of the indicators that such cross-lineage recombinations are post-oncogenic events. 2, 31 Comparative immunogenotypic analysis of pediatric and adult T-ALL subgroups showed largely similar TCRG gene rearrangement patterns. This confirms our previous observation and is in striking contrast to precursor-B-ALL, where immunoglobulin and TCR gene rearrangement patterns are clearly less mature in adults than in children. 16 Comparison of TCRG gene configurations between the three major immunophenotypic T-ALL subgroups revealed limited but significant differences. The TCR␥␦ + subgroup was distinct from non-TCR␥␦ cases with respect to a more frequent usage of the more downstream V␥ segments (with a striking preference for V␥9) and the more upstream J␥1 segments (particularly J␥1.3). This might reflect the rapid cessation of TCRG gene accessibility to V(D)J recombinase activity as soon as a functional TCRG gene rearrangement has been achieved. This is in line with a previous hypothesis that TCR␥␦ + T-ALL should be regarded as cells that branched off T cell development at an early stage of completion of TCRD and TCRG gene rearrangement processes, while the recombinase activity is still retained. 17, 21, 31 Retained V(D)J activity is for instance reflected by the frequent occurrence of complete V␤-J␤ and cross-lineage IGH gene rearrangements, detectable in 60% and 50% of TCR␥␦ + T-ALL patients, respectively. 17, 32 We could not confirm the previous observation of Hara et al 11 suggesting that in CD3 − T-ALL V␥ genes more proximal to J␥ are more frequently rearranged, whereas CD3 + T-ALL show a high frequency of rearrangements involving V␥ genes more distal from J␥. We believe that this might be a bias owing to the relatively small group of T-ALL (24 cases) studied.
Our study also aimed at establishment of an optimal PCR strategy for identification of clonal TCRG gene rearrangements as molecular targets for MRD monitoring in T-ALL patients. Using five principal V␥-J␥ primer combinations (Table 3) , we found 94% of clonal TCRG gene rearrangements. These five primer combinations detected at least one rearrangement in all but one T-ALL patient with rearranged TCRG genes. Therefore, we routinely apply this set of primers on new diagnostic T-ALL samples. With three supplementary V␥-J␥ primer combinations (Table 3) , an additional 3% of clonal rearrangements were detected. This set may be reserved for T-ALL cases nega- tive with the first set of primers, while SB analysis can be limited to rare cases with questionable PCR results. Occurrence of TCRG gene rearrangements in virtually all patients, easy detectability of these rearrangements, and rare oligoclonality make TCRG genes principal molecular targets for MRD monitoring in T-ALL, particularly when TCRD genes are deleted. The only potential disadvantage is a decreased sensitivity of patient-specific PCR owing to competition with TCRG gene rearrangements in normal T cells. Nevertheless, in the extensive study of the BIOMED-1 Concerted Action, 86% of TCRG targets reached a sensitivity of at least 10 −4 , which is a prerequisite for reliable identification of MRDbased risk groups. 7, 24 Moreover, the 'end-stage' character of most TCRG gene rearrangements in T-ALL probably results in stability during the disease course. This was also suggested by several studies comparing TCRG gene configuration at diagnosis and at relapse of T-ALL. 7, [33] [34] [35] [36] [37] Interestingly, a single study by Taylor et al 37 described a so-called clonal regression in two T-ALL patients with biallelic TCRG gene rearrangements at diagnosis and both alleles in germline configuration at relapse. This observation was not confirmed by other studies, which showed that clonal evolution of TCRG genes is a rare event in T-ALL, and if clonal evolution occurred, this mainly concerned 'non-end-stage' rearrangements resulting in ongoing recombination of more upstream V␥ and more downstream J␥ segments. 7, 33, 34, 36 In conclusion, we could determine the TCRG gene configuration in a large group of T-ALL patients, showing biallelic gene rearrangements in the vast majority of cases. Analysis of different immunophenotypic subsets showed that TCR␥␦ + T-ALL are characterized by a less mature TCRG gene configuration when compared to CD3 − and TCR␣␤ + cases. Since the majority of TCRG gene rearrangements in T-ALL represent 'end-stage' recombinations, they presumably are relatively stable molecular MRD targets. Based on our study, we propose a rapid and easy heteroduplex PCR strategy enabling identification of approximately 95% of clonal TCRG gene rearrangements with only five primer combinations, resulting in at least one MRD-PCR target in 95% of T-ALL patients and two PCR targets in 84% of cases.
